Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings.

Autor:	Iruzubieta P; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain., Santos-Laso A; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain., Arias-Loste MT; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain., Calleja JL; Gastroenterology Department, Hepatology Unit, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain., Crespo J; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain. Electronic address: javiercrespo1991@gmail.com.
Jazyk:	angličtina
Zdroj:	Journal of hepatology [J Hepatol] 2024 Mar; Vol. 80 (3), pp. e121-e123. Date of Electronic Publication: 2023 Oct 26.
DOI:	10.1016/j.jhep.2023.10.026
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect